Trypanosoma cruzi infection results in an increase in intracellular cholesterol

Christopher Johndrow1, Randin Nelson2, Herbert Tanowitz3

  • 1Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA.

Microbes and Infection
|February 4, 2014
PubMed

Insights

Trypanosoma cruzi infection leads to cholesterol buildup in tissues, potentially contributing to Chagasic cardiomyopathy. This occurs as the parasite invades cells using the low-density lipoprotein receptor, altering host cholesterol regulation.

Area of Science:

  • Cardiovascular Diseases
  • Infectious Diseases
  • Molecular Biology

Background:

  • Chagasic cardiomyopathy, caused by Trypanosoma cruzi, is a significant health issue.
  • Trypanosoma cruzi utilizes host low-density lipoprotein receptor (LDLr) for invasion, showing an affinity for lipoproteins.

Purpose of the Study:

  • To investigate the role of cholesterol accumulation in Trypanosoma cruzi infection and Chagasic cardiomyopathy.
  • To explore the mechanisms by which T. cruzi affects host cell cholesterol homeostasis.

Main Methods:

  • Analysis of tissue samples from murine models of acute and chronic Chagas disease.
  • Examination of tissue from a human Chagasic cardiomyopathy case.
  • In vitro studies of T. cruzi infection in cultured cells with varying cholesterol levels.
  • Investigation of intracellular cholesterol regulation in infected host cells.

Main Results:

  • T. cruzi infection was associated with LDL and cholesterol accumulation in tissues of infected mice and a human patient.
  • Increased cholesterol levels in the culture medium enhanced T. cruzi invasion of host cells.
  • Infected host cells exhibited altered cholesterol regulation.
  • T. cruzi invasion via LDLr appears to mediate changes in intracellular cholesterol homeostasis.

Conclusions:

  • Trypanosoma cruzi infection disrupts host cholesterol homeostasis, leading to lipid accumulation.
  • Elevated intracellular lipids and associated oxidative stress may contribute to the pathogenesis of Chagasic cardiomyopathy.
  • Targeting LDLr-mediated invasion and cholesterol metabolism could be a therapeutic strategy for Chagas disease.